Rapid determination of methadone in plasma, cerebrospinal fluid, and urine by gas chromatography and its application to routine drug monitoring.
Determination of methadone (MET) in biological fluids can serve to adjust dosages in patients suffering from cancer pain or participating in methadone maintenance programs. We developed a gas chromatographic assay using nitrogen-phosphorus detection. The method involves a single-step extraction from alkalized plasma, cerebrospinal fluid, or urine into n-hexane/isoamyl-alcohol (99/1, v/v). Dextropropoxyphene was used as internal standard. Separation was achieved with a silica SE-52-CB column (13 m x 0.25-mm I.D.). The method was validated for the determination of MET in plasma, urine, and cerebrospinal fluid with a quantification limit of 0.5 ng/mL. The coefficients of variation for within-day and between-day precision were within 10.2 and 14.1%, respectively. Approximately 100 samples can be analyzed by one person in the course of a working day, making the method applicable to routine drug monitoring. The method was demonstrated to be sensitive and accurate for pharmacokinetic studies in plasma, urine, or cerebrospinal fluid.
Schmidt
N
N
Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuernberg, Germany.
Sittl
R
R
Brune
K
K
Geisslinger
G
G
D002849:Chromatography, Gas; D002908:Chronic Disease; D016903:Drug Monitoring; D006556:Heroin Dependence / Q000097:blood / Q000134:cerebrospinal fluid / Q000652:urine; D006801:Humans; D008691:Methadone / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid / Q000652:urine; D010146:Pain / Q000097:blood / Q000134:cerebrospinal fluid / Q000652:urine; D011786:Quality Control; D013237:Stereoisomerism
D008691:Methadone